Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Bril

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Obesity (Silver Spring, Md.)|December 28, 2023
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by raceFernando Bril, Meagan Gray
Annals of Internal Medicine|February 7, 2017
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic SteatohepatitisFernando Bril, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|June 22, 2019
Letter to the Editor: "Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content"Fernando Bril, Kenneth Cusi
Diabetes Care|August 24, 2018
Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192Fernando Bril, Kenneth Cusi
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2015
Response to do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?Fernando Bril, Kenneth Cusi
Current Hypertension Reviews|December 11, 2020
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the LiverEddison Godinez-Leiva, Fernando Bril
Journal of Hepatology|June 19, 2021
Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?""Fernando Bril, David M Fettig
The Journal of Clinical Endocrinology and Metabolism|June 26, 2024
Response to Letter to the Editor From de Zegher and Ibáñez: "Adipose Tissue Dysfunction in Polycystic Ovary Syndrome"Fernando Bril, Lauren Pace, Ricardo Azziz
The Lancet Regional Health. Europe|June 10, 2026
Closing the Implementation Gap: New Models of Care to End Chronic Liver DiseaseFernando Bril, Fasiha Kanwal, Kenneth Cusi
Clinics in Liver Disease|April 6, 2023
Metabolic Syndrome and Its Association with Nonalcoholic SteatohepatitisFernando Bril, Arun Sanyal, Kenneth Cusi
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Obesity (Silver Spring, Md.)|December 28, 2023
Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by raceFernando Bril, Meagan Gray
Annals of Internal Medicine|February 7, 2017
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic SteatohepatitisFernando Bril, Kenneth Cusi
The Journal of Clinical Endocrinology and Metabolism|June 22, 2019
Letter to the Editor: "Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content"Fernando Bril, Kenneth Cusi
Diabetes Care|August 24, 2018
Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192Fernando Bril, Kenneth Cusi
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2015
Response to do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent?Fernando Bril, Kenneth Cusi
Current Hypertension Reviews|December 11, 2020
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the LiverEddison Godinez-Leiva, Fernando Bril
Journal of Hepatology|June 19, 2021
Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?""Fernando Bril, David M Fettig
The Journal of Clinical Endocrinology and Metabolism|June 26, 2024
Response to Letter to the Editor From de Zegher and Ibáñez: "Adipose Tissue Dysfunction in Polycystic Ovary Syndrome"Fernando Bril, Lauren Pace, Ricardo Azziz
The Lancet Regional Health. Europe|June 10, 2026
Closing the Implementation Gap: New Models of Care to End Chronic Liver DiseaseFernando Bril, Fasiha Kanwal, Kenneth Cusi
Clinics in Liver Disease|April 6, 2023
Metabolic Syndrome and Its Association with Nonalcoholic SteatohepatitisFernando Bril, Arun Sanyal, Kenneth Cusi
Pageof 10